Overall rank by patents
#19,578
Across all tracked assignees
USPTO PatentsView assignee record - 14 granted patents across 5 technology areas, active 2016–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G21H (OBTAINING ENERGY FROM RADIOACTIVE SOURCES; APPLICATIONS OF RADIATION FROM RADIOACTIVE SOURCES, NOT OTHERWISE PROVIDED FOR; UTILISING COSMIC RADIATION).
The verdict
CITY holds 14 US patents across 5 technology areas, rank #19,578 of 50,000 tracked assignees.
CITY LABS, Inc. has been granted 14 US utility patents between 2016 and 2024, placing CITY LABS, Inc. at rank #19,578 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.8 claims per patent with primary concentration in G21H (OBTAINING ENERGY FROM RADIOACTIVE SOURCES; APPLICATIONS OF RADIATION FROM RADIOACTIVE SOURCES, NOT OTHERWISE PROVIDED FOR; UTILISING COSMIC RADIATION). As a US Corporation, CITY LABS, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, CITY sits between Checkmate Lifting & Safety Ltd (14 patents, rank #19,574) and Clearag, Inc. (14 patents, rank #19,582) - the closest US assignees by grant volume. The composite Innovation Score of 39.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 8 grants, compared with 6 in the 2015–2019 window, a +33% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. CITY LABS, Inc.'s 14.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark CITY LABS, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CHECKMATE LIFTING & SAFETY LTD
14 patents
CHINA PNEUMATIC CORPORATION
14 patents
CHINA WONDERLAND NURSERYGOODS CO., LTD
14 patents
CIMA S.P.A.
14 patents
CJ Healthcare Corporation
14 patents
CLAAS Industrietechnik GmbH
14 patents
CLARKE MOSQUITO CONTROL PRODUCTS, INC.
14 patents
CLEARAG, INC.
14 patents
CITY LABS, INC.
14 patents
What this shows CITY holds 14 patents at rank #19,578, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #19,578 in granted patent volume.
Other assignees with the most granted patents in CITY's primary technology class.
CITY's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
39 Top 38% higher than 62% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 7.1% |
| 2017 | 3 | 21.4% |
| 2018 | 1 | 7.1% |
| 2019 | 1 | 7.1% |
| 2020 | 1 | 7.1% |
| 2021 | 1 | 7.1% |
| 2022 | 2 | 14.3% |
| 2023 | 1 | 7.1% |
| 2024 | 3 | 21.4% |
Top 5 of 5 technology areas
Overall rank by patents
#19,578
Across all tracked assignees
39.5 out of 100
How to use this portfolio
CITY's 14 grants land it in the top 38% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.